NCT00150293已完成3 期
Pregabalin Open-Label Add-On Trial: An Open-Label, Multicenter Follow-On Study to Determine Long-Term Safety and Efficacy in Patients With Partial Seizures.
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- Pfizer
- 入组人数
- 337
- 试验地点
- 83
- 主要终点
- Safety Efficacy
研究概览
简要总结
To determine long-term safety and efficacy of pregabalin in patients with partial seizures.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Must have met the inclusion criteria for preceding double-blind study
- •Have received double-blind study medication and wish to receive open-label pregabalin.
排除标准
- •Cannot be pregnant or considering becoming pregnant during the course of the study.
- •Cannot be receiving any concomitant medication that could alter the effectiveness of the pregabalin response or affect seizure frequency.
结局指标
主要结局
Safety Efficacy
次要结局
未报告次要终点
研究者
研究点 (83)
Loading locations...
相似试验
已完成
3 期
To Evaluate the Long-Term Safety and Efficacy of Pregabalin in Patients With Partial SeizuresSeizure Disorder, PartialNCT00141388Pfizer455
已完成
3 期
To Evaluate the Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures.Seizure Disorder, PartialNCT00141336Pfizer750
已完成
3 期
To Evaluate Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures.Seizure Disorder, PartialNCT00141245Pfizer325
已完成
2 期
To Evaluate the Long-Term Safety of Pregabalin in Refractory Partial Epilepsy.Epilepsy, PartialNCT00141414Pfizer82
已完成
3 期
Pregabalin Open-Label Extension Trial in Patients With Partial SeizuresEpilepsies, PartialEpilepsy, Complex PartialNCT00143143Pfizer300